Skip to content

AOCI at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$2.5B-6.6%
Danaher logo
DanaherDHR
-$593M+63.2%
Agilent Technologies logo
Agilent TechnologiesA
-$202M+27.9%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
-$125.2M+39.1%
Element Solutions logo
Element SolutionsESI
-$292.9M+28.5%
Westlake logo
WestlakeWLK
-$99M+23.8%

Other financials

Income statement

See full
Revenue$1.6B0.0%
Gross profit$500.7M-6.4%
Operating income$99.5M-32.5%
Net income$43.3M-32.9%
EPS (diluted)$0.06-33.3%

Balance sheet

See full
Cash & equivalents$282.2M-11.4%
Total debt$3.8B-7.1%
Total equity$5.6B-8.4%
Total assets$11.7B-5.4%

Cash flow

See full
Operating cash flow$58.7M-46.3%
CapEx$33.5M+19.6%
Free cash flow$25.2M-69.0%

Valuation

See full
Market cap$6.54B-52.0%
Enterprise value$10.07B-40.4%
P/S-1.0×

Profitability

See full
Gross margin32.1%-1.4pp
Operating margin4%-5.2pp
Net margin-9.2%-19.9pp
FCF margin6.7%-3.3pp

Returns & leverage

See full
Return on equity-10.3%-22.8pp
Debt / equity0.7×0.0×
Current ratio1.8×+0.6×

Where this comes from

Reported directly by Avantor in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Avantor’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avantor's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avantor's AOCI?
Avantor (AVTR) reported AOCI of -$43.7M in Q1 2026.
How has Avantor's AOCI changed year-over-year?
Avantor's AOCI increased by 62.9% year-over-year, from -$117.7M to -$43.7M.
What is the long-term trend for Avantor's AOCI?
Over 5 years (2020 to 2025), Avantor's AOCI has grown at a -4.9% compound annual growth rate (CAGR), from $21.7M to -$16.9M.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.